Theravance Biopharma, Inc.
SEC Filing List
TBPH CIK: 0001583107
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-Q | Quarterly report pursuant to Section 13 ... | Theravance Biopharma, Inc. | Toppan Merrill/FA | 05/07/2026 | |
| 8-K | Current report filing | Theravance Biopharma, Inc. | Toppan Merrill/FA | 05/07/2026 | |
| DEF 14A | Definitive proxy statements | Theravance Biopharma, Inc. | Toppan Merrill/FA | 04/28/2026 | |
| 4 | Statement of changes in beneficial owner... | Winningham Rick E | Theravance Biopharma, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Grimaud Brett A. | Theravance Biopharma, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Farnum Rhonda | Theravance Biopharma, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Sawaf Aziz | Theravance Biopharma, Inc. | 04/03/2026 | |
| 8-K | Current report filing | Theravance Biopharma, Inc. | Toppan Merrill/FA | 03/30/2026 | |
| SCHEDULE 13D/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/25/2026 | |||
| 10-K | Annual report pursuant to Section 13 and... | Theravance Biopharma, Inc. | Toppan Merrill/FA | 03/23/2026 | |
| No record found. | |||||
| Load More | |||||
